Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

EMTN Programme Supplementary Prospectus

1 Jul 2025 12:55

RNS Number : 2446P
Sainsbury(J) PLC
01 July 2025
 

1 July 2025

 

EMTN PROGRAMME PUBLICATION OF SUPPLEMENTARY PROSPECTUS

J Sainsbury plc

(the "Company")

 

The following supplementary prospectus has been approved by the Financial Conduct Authority and is available for viewing:

 

The supplementary prospectus dated 1 July 2025 (the "Supplementary Prospectus") supplementing the base prospectus (the "Prospectus") dated 17 January 2025 relating to the establishment of the £5,000,000,000 Euro Medium Term Note Programme, with J Sainsbury plc as the issuer.

 

The Supplementary Prospectus incorporates by reference the audited financial statements of the Company for the 52-week period ended on 1 March 2025.

 

The Supplementary Prospectus should be read and construed in conjunction with the Prospectus.

 

The full document can be viewed at: http://www.rns-pdf.londonstockexchange.com/rns/2446P_1-2025-7-1.pdf

 

A copy of the Prospectus has been submitted to the Financial Conduct Authority's Electronic Submission Service and may shortly be viewed on the National Storage Mechanism (NSM) at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

J Sainsbury plc LEI Number: 213800VGZAAJIKJ9Y484

 

Enquiries

Investor Relations Media

James Collins Rebecca Reilly

 +44 (0) 7801 813 074 +44 (0) 20 7695 7295

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. The Prospectus is not intended for use in the United States and is not addressed or targeted at U.S. persons and should not be relied upon by any U.S. person. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFFLFBEDLZBBX
Date   Source Headline
2nd Jun 20263:04 pmRNSAnnual Report and Notice of AGM 2026
1st Jun 20262:00 pmRNSDirector/PDMR Shareholding
1st Jun 20261:00 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
8th May 20263:30 pmRNSDirector/PDMR Shareholding
8th May 20267:00 amRNSTransaction in Own Shares
1st May 20262:30 pmRNSDirector/PDMR Shareholding
1st May 20261:00 pmRNSTotal Voting Rights
1st May 202610:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20263:15 pmRNSDirector/PDMR Shareholding
27th Apr 20262:00 pmRNSPresentation via Investor Meet Company
24th Apr 20264:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSCommencement of Share Buyback Programme
23rd Apr 20267:00 amRNSPreliminary Results
10th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 20263:50 pmRNSTotal Voting Rights
1st Apr 20262:30 pmRNSHolding(s) in Company
13th Mar 20263:30 pmRNSDirector/PDMR Shareholding
10th Mar 20263:30 pmRNSHolding(s) in Company
10th Mar 20263:30 pmRNSHolding(s) in Company
5th Mar 20263:00 pmRNSAdditional Listing
2nd Mar 20261:00 pmRNSTotal Voting Rights
13th Feb 20263:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:20 pmRNSTotal Voting Rights
23rd Jan 20262:15 pmRNSEMTN Programme Publication of Base Prospectus
20th Jan 20267:00 amRNSTransaction in Own Shares and Programme Completion
19th Jan 20263:25 pmRNSBlock listing Interim Review
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20262:30 pmRNSDirector/PDMR Shareholding
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20262:00 pmRNSDirector/PDMR Shareholding
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:05 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTrading Statement
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20262:04 pmRNSTransaction in Own Shares - Replacement
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20263:30 pmRNSHolding(s) in Company
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20261:00 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20251:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.